DNA cleavage activities of Staphylococcus aureus gyrase and topoisomerase IV stimulated by quinolones and 2-pyridones

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1574-1577

  Saiki, Anne Y C ^a   Shen, Linus L ^a   Chen, Chih Ming ^a   Baranowski, John ^a   Lerner, Claude G ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRIDONE DERIVATIVE; 8 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 7 FLUORO 9 METHYL 4 OXO 3 QUINOLIZINECARBOXYLIC ACID; BACTERIAL PROTEIN; CIPROFLOXACIN; CLINAFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; GLUTAMIC ACID DERIVATIVE; NORFLOXACIN; OXOLINIC ACID; QUINOLONE DERIVATIVE; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DNA CLEAVAGE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PURIFICATION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

EID: 0032803906     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1574     Document Type: Article

References (30)

1. Blanche, F., B. Cameron, F. X. Bernard, L. Maton, B. Manse, L. Ferrero, N. Ratet, C. Lecoq, A. Goniot, D. Bisch, and J. Crouzet. 1996. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Antimicrob. Agents Chemother. 40:2714-2720.
2. Brockbank, S. M., and P. T. Barth. 1993. Cloning, sequencing, and expression of the DNA gyrase genes from Staphylococcus aureus. J. Bacteriol. 175:3269-3277.
3. Chen, C. R., M. Malik, M. Snyder, and K. Drlica. 1996. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J. Mol. Biol. 258:627-637.
4. Deguchi, T., A. Fukuoka, M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Nishino, S. Ishihara, Y. Ban, and Y. Kawada. 1997. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 41:699-701.
5. Drlica, K., and X. L. Zhao. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392.
6. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
7. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
8. Flamm, R. K., C. Vojtko, D. T. Chu, Q. Li, J. Beyer, D. Hensey, N. Ramer, J. J. Clement, and S. K. Tanaka. 1995. In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor. Antimicrob. Agents Chemother. 39:964-970.
9. Gellert, M. 1981. DNA topoisomerases. Annu. Rev. Biochem. 50:879-910.
10. George, J. T., and I. Morrissey. 1998. Activity of levofloxacin, ofloxacin, ciprofloxacin, and sparfloxacin against DNA gyrase from S. pneumoniae C3LN4, abstr. C-176, p. 120. In Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Georgopapadakou, N. H., and B. A. Dix. 1986. Purification of Staphylococcus aureus DNA gyrase and inhibition by quinolones, abstr. A-33. In Abstracts of the 86th Annual Meeting of the American Society for Microbiology 1986. American Society for Microbiology, Washington, D.C.
12. Gubbins, E. J., K. L. Pohlman, J. A. Lee, H. T. Smith, J. M. Parry, and R. L. Simmer. 1997. The universal cloning site system for designing gene expression cassettes and vectors. Protein Eng. 10:27.
13. Hoshino, K., A. Kitamura, I. Morrissey, K. Sato, J. Kato, and H. Ikeda. 1994. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob. Agents Chemother. 38:2623-2627.
14. Hsiang, Y.-H., R. Hertzberg, S. Hecht, and L. F. Liu. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:14873-14878.
15. Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
16. Liu, L. F., T. C. Rowe, L. Yang, K. M. Tewey, and G. L. Chen. 1983. Cleavage of DNA by mammalian DNA topoisomerase II. J. Biol. Chem. 258:15365-15370.
17. Munoz, R., and A. G. De La Campa. 1996. ParC subunit of DNA topoisomerase-IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
18. Nakanishi, N., S. Yoshida, H. Wakebe, M. Inoue, T. Yamaguchi, and S. Mitsuhashi. 1991. Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 35:2562-2567.
19. Ng, E. Y., M. Trucksis, and D. C. Hooper. 1996. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1881-1888.
20. Okuda, J., S. Okamoto, M. Takahata, and T. Nishino. 1991. Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 35:2288-2293.
21. Onodera, Y., Y. Uchida, M. Tanaka, and K. Sato. 1998. Dual inhibitory activity of DU-6859a against DNA gyrase and topoisomerase IV of Streptococcus pneumoniae, abstr. C-175, p. 119. In Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Pan, X. S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
23. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
24. Shen, L. L., J. Baranowski, J. Fostel, D. A. Montgomery, and P. A. Lartey. 1992. DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs. Antimicrob. Agents Chemother. 36:2778-2784.
25. Takahata, M., and T. Nishino. 1988. DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity. Antimicrob. Agents Chemother. 32:1192-1195.
26. Tanaka, M., Y. Onodera, Y. Uchida, and K. Sato. 1998. Quinolone resistance mutants in the GyrB protein of Staphylococcus aureus. Antimicrob. Agents Chemother. 42:3044-3046.
27. Tanaka, M., Y. Onodera, Y. Uchida, K. Sato, and I. Hayakawa. 1997. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus. Antimicrob. Agents Chemother. 41: 2362-2366.
28. Tanaka, M., K. Sato, Y. Kimura, I. Hayakawa, Y. Osada, and T. Nishino. 1991. Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Antimicrob. Agents Chemother. 35:1489-1491.
29. Wang, J. C. 1985. DNA topoisomerases. Annu. Rev. Biochem. 54:665-697.
30. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.